Category 5 - DIAGNOSTIC IMAGING SERVICES
61646 - Additional Information
Item Start Date:
14-Jan-2002
Description Updated:
01-Jul-2011
Schedule Fee Updated:
14-Jan-2002
Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET
Whole body FDG PET study for the evaluation of patients with suspected residual or recurrent sarcoma (excluding gastrointestinal stromal tumour) after the initial course of definitive therapy to determine suitability for subsequent therapy with curative intent. (R)
Fee: $999.00 Benefit: 75% = $749.25 85% = $900.30
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change